CSGALNACT2 Antibody (Center)
Affinity Purified Rabbit Polyclonal Antibody (Pab)
- 产品详情
- 文献引用 : 1
- 实验流程
- 背景知识
Application ![]()
| IHC-P, FC, WB, E |
---|---|
Primary Accession | Q8N6G5 |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | Rabbit IgG |
Calculated MW | 62572 Da |
Antigen Region | 200-229 aa |
Gene ID | 55454 |
---|---|
Other Names | Chondroitin sulfate N-acetylgalactosaminyltransferase 2, Chondroitin beta-1, 4-N-acetylgalactosaminyltransferase 2, Beta4GalNAcT-2, GalNAcT-2, CSGALNACT2, CHGN2, GALNACT2 |
Target/Specificity | This CSGALNACT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 200-229 amino acids from the Central region of human CSGALNACT2. |
Dilution | IHC-P~~1:100~500 FC~~1:10~50 WB~~1:1000 E~~Use at an assay dependent concentration. |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | CSGALNACT2 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | CSGALNACT2 |
---|---|
Synonyms | CHGN2, GALNACT2 |
Function | Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). Required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains. |
Cellular Location | Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein |
Tissue Location | Ubiquitous. |
Research Areas
For Research Use Only. Not For Use In Diagnostic Procedures.

Application Protocols
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). It is required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains.
REFERENCES
Yu Y., et.al., Genome Res. 11:1392-1403(2001).

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.